company background image
ARAY

Accuray NasdaqGS:ARAY Stock Report

Last Price

US$2.24

Market Cap

US$209.6m

7D

7.7%

1Y

-42.0%

Updated

04 Oct, 2022

Data

Company Financials +
ARAY fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance0/6
Financial Health5/6
Dividends0/6

ARAY Stock Overview

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region.

Accuray Incorporated Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Accuray
Historical stock prices
Current Share PriceUS$2.24
52 Week HighUS$5.93
52 Week LowUS$1.70
Beta1.75
1 Month Change-5.09%
3 Month Change11.44%
1 Year Change-41.97%
3 Year Change-14.83%
5 Year Change-47.29%
Change since IPO-92.13%

Recent News & Updates

Sep 30

Accuray launches CyberKnife platform in Africa for cancer patients

Accuray (NASDAQ:ARAY) said it had launched its CyberKnife platform in Africa for more patients to receive treatments with stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) the system delivers. CyberKnife platform can treat certain neurologic conditions and a wide range of tumor types throughout the body, and at various stages of disease. The entire CyberKnife procedure is typically completed in just 1 to 5 out-patient sessions, providing a shorter overall course of treatment compared to conventional radiation therapy which typically takes 30-40 sessions.

Shareholder Returns

ARAYUS Medical EquipmentUS Market
7D7.7%6.4%4.4%
1Y-42.0%-25.7%-18.2%

Return vs Industry: ARAY underperformed the US Medical Equipment industry which returned -27.3% over the past year.

Return vs Market: ARAY underperformed the US Market which returned -20% over the past year.

Price Volatility

Is ARAY's price volatile compared to industry and market?
ARAY volatility
ARAY Average Weekly Movement9.6%
Medical Equipment Industry Average Movement8.5%
Market Average Movement6.9%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: ARAY is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: ARAY's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19901,044Suzanne Winterhttps://www.accuray.com

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day.

Accuray Incorporated Fundamentals Summary

How do Accuray's earnings and revenue compare to its market cap?
ARAY fundamental statistics
Market CapUS$209.62m
Earnings (TTM)-US$5.35m
Revenue (TTM)US$429.91m

0.5x

P/S Ratio

-39.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ARAY income statement (TTM)
RevenueUS$429.91m
Cost of RevenueUS$269.95m
Gross ProfitUS$159.96m
Other ExpensesUS$165.30m
Earnings-US$5.35m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.057
Gross Margin37.21%
Net Profit Margin-1.24%
Debt/Equity Ratio339.3%

How did ARAY perform over the long term?

See historical performance and comparison